Investigating Prime-Pull Vaccination through a Combination of Parenteral Vaccination and Intranasal Boosting


Authors: C.B. Roces, M.T. Hussain, S.T. Schmidt, D. Christensen and Y. Perrie

Journal: Vaccines

DOI: 10.3390/vaccines8010010

Publication - Abstract

December 31, 2019

Abstract


Scientists from the Institute of Pharmacy and Biomedical Science at the University of Strathclyde confirm the ability of PLGA polymeric nanoparticles in a dry powder form to successfully deliver an encapsulated antigen payload intranasally for uptake in cells residing in the deep lungs infected by Mycobacterium tuberculosis. Using the NanoAssemblr® Benchtop to synthesize PLGA nanoparticles with a H56 tuberculosis (TB) antigen, the particles were applied to three macrophage cell lines and functioned as a mucosal booster in a prime-pull immunization protocol demonstrating a high retention of antigen immunogenicity. Observations in antigen uptake, processing, and relevant T-cell mediated immune responses against Mycobacterium tuberculosis were outlined having emphasis on the significance of T cell location in relation to the infected macrophages as a factor affecting the efficacy of novel vaccines. This research serves as evidence of the NanoAssemblr® platform's ability to drive future studies toward the development of novel subunit vaccines against tuberculosis and paves the way for further investigations on the capacity of PLGA nanoparticles to function as vaccine boosters.

Advanced Search

close
  • Publications
  • Application Notes
  • Posters
  • Workshops
  • Videos & Webinars
  • Blog Posts
Search

Browse by Category

  • Application
    • Diagnostic and Imaging
    • Genetic Medicine
    • Hematology
    • Metabolic Disorders
    • Neuroscience
    • Oncology
    • Skeletal Disorders
    • Targeted Drug Delivery
    • Vaccines
    • Other Applications
    • Cell therapy
  • Formulation
    • Liposomes
    • Nucleic Acid Lipid Nanoparticles
    • Polymeric Nanoparticles
    • Other Formulations
  • Payload
    • DNA
    • microRNA
    • mRNA
    • siRNA
    • Small Molecule Drugs
    • Other Payloads


related content

Publication - Abstract

Nanoparticles provide a unique opportunity to explore the benefits of selective distribution and release of cancer therapeutics at sites of disease through varying particle sizes and compositions that exploit the enhanced permeability of tumor-associated blood vessels.
Read More


Publication - Abstract

Niosome nanoparticles can be prepared using different methods, each of which can affect the size and homogeneity of the prepared particles. The aim of this study was to establish if the method of preparation impacted on the prepared vesicles when loaded with a model protein and t...
Read More


Sign Up and Stay Informed
Sign up today to automatically receive new Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.